Live Breaking News & Updates on Department Of Orbital

Stay updated with breaking news from Department of orbital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ACELYRIN, INC. Announces Lonigutamab Phase 1/2 Proof-Of-Concept Data to be Shared During Late-Breaking Oral Presentation at ENDO 2024

Lonigutamab is the first subcutaneous anti-IGF-1R to demonstrate clinical responses in thyroid eye disease patients LOS ANGELES, May 29, 2024 ACELYRIN, INC. , a late-stage clinical biopharma. ....

United States , Jules Stein Eye Institute , San Francisco Bay , Los Angeles , Shoaib Ugradar , Tyler Marciniak , Exchange Commission , Department Of Orbital , University Of California , Endocrine Society Annual Meeting , Endocrine Society , Annual Meeting , Oculoplastic Surgery , Private Practice , Eye Disease , Annual Report , Investor Relations ,